Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

Robert Eriksson, Brian V. Broberg, Pelle L. Ishoy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jorgensen, Filip K. Knop, Bjørn H. Ebdrup

4 Citations (Scopus)
22 Downloads (Pure)
Original languageEnglish
Article number781
JournalFrontiers in Psychiatry
Volume9
Number of pages7
ISSN1664-0640
DOIs
Publication statusPublished - 2019

Keywords

  • exenatide
  • procollagen type I N-terminal propeptide (PINP)
  • C-terminal cross-linking telopeptide of type I collagen (CTX)
  • bone mineral density
  • randomized controlled trial

Fingerprint

Dive into the research topics of 'Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density'. Together they form a unique fingerprint.

Cite this